Burden of asthma among patients adherent to ICS/LABA: A real-world study

References

• National Institutes of Health. Asthma. 2017. Available at: https://www.nhlbi.nih.gov/health/health-topics/topics/asthma [accessed 2017 Nov 14].
   Google Scholar
• American College of Allergy, Asthma and Immunology. Asthma information. 2016. Available at: http://acaai.org/asthma/about [accessed 2017 Nov 14].
   Google Scholar
• National Center for Health Statistics. Asthma. 2017. Available at: http://www.cdc.gov/nchs/fastats/asthma.htm [accessed 2017 Nov 14].
   Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention-Online Appendix. 2017a. Available at: http://ginasthma.org/2017-online-appendix-global-strategy-for-asthma-management-and-prevention [accessed 2017 Nov 14].
   Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017b. Available at: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/ [accessed 2017 Nov 14].
   Google Scholar
• Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med. 2006;100:1139–51. doi:10.1016/j.rmed.2006.03.031.
   PubMed Web of Science ®Google Scholar
• Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008;31:320–5. doi:10.1183/09031936.00039707.
   PubMed Web of Science ®Google Scholar
• van Boven JF, Ryan D, Eakin MN, Canonica GW, Barot A, Foster JM, Respiratory Effectiveness Group. Enhancing respiratory medication adherence: the role of health care professionals and cost-effectiveness considerations. J Allergy Clin Immunol Pract. 2016;4:835–46. doi:10.1016/j.jaip.2016.03.007.
   PubMed Web of Science ®Google Scholar
• Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J. 2002;19:246–51. doi:10.1183/09031936.02.00218402.
   PubMed Web of Science ®Google Scholar
• Fletcher M, Jha A, Dunlop W, Heron L, Wolfram V, Van der Molen T, Price D. Patient reported burden of asthma on resource use and productivity across 11 countries in Europe. Adv Ther. 2015;32:370–80. doi:10.1007/s12325-015-0204-6.
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Canvin J, Peachey G, Chen CW, Georgiou P. Healthcare resource utilization in patients receiving omalizumab for allergic asthma in a real-world setting. Biol Ther. 2014;4:57–67. doi:10.1007/s13554-014-0019-z.
   PubMedGoogle Scholar
• Sadatsafavi M, Rousseau R, Chen W, Zhang W, Lynd L, FitzGerald JM, Economic Burden of Asthma Study Team. The preventable burden of productivity loss due to suboptimal asthma control: a population-based study. Chest. 2014;145:787–93. doi:10.1378/chest.13-1619.
   PubMed Web of Science ®Google Scholar
• Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand. Curr. Med. Res. Opin. 2008;24:3063–72. doi:10.1185/03007990802457040.
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65. doi:10.1016/j.jaci.2003.09.008.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–65. doi:10.2165/00019053-199304050-00006.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54. doi:10.1111/j.1751-7176.2008.07572.x.
   PubMed Web of Science ®Google Scholar
• Reilly Associates. WPAI scoring. 2002. Available at: http://www.reillyassociates.net/WPAI_Scoring.html [accessed 2017 Nov 14].
   Google Scholar
• Janežič A, Locatelli I, Kos M. Criterion validity of 8-item morisky medication adherence scale in patients with asthma. PLoS One. 2017;12(11). Epub 2017 Nov 30. doi.org/10.1371/journal.pone.0187835.
   Web of Science ®Google Scholar
• Smits D, Brigis G, Pavare J, Maurina B, Barengo NC. Factors related to good asthma control using different medical adherence scales in Latvian asthma patients: an observational study. NPJ Prim Care Respir Med. 2017;27:39. Epub 2017 Jun 20. doi:10.1038/s41533-017-0042-x.
   PubMed Web of Science ®Google Scholar
• ICC/ESOMAR. International Code on Market and Social Research. 2007. Available at: https://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_English_.pdf [accessed 2017 Nov 15].
   Google Scholar
• U.S. Department of Health and Human Services. Summary of the HIPAA Privacy Rule. May 2003. Available at: http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/privacysummary.pdf [accessed 2017 Nov 15].
   Google Scholar
• Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH, TENOR Study Group. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health. 2008;11:231–9. doi:10.1111/j.1524-4733.2007.00229.x.
   PubMed Web of Science ®Google Scholar
• Al Efraij K, FitzGerald JM. Current and emerging treatments for severe asthma. J Thorac Dis. 2015;7(11):E522–5.
   PubMed Web of Science ®Google Scholar
• Lang DM. Severe asthma: epidemiology, burden of illness, and heterogeneity. Allergy Asthma Proc. 2015;36(6):418–24. doi:10.2500/aap.2015.36.3908.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International study group. N Engl J Med. 1997 Nov 13;337(20):1405–11. doi:10.1056/NEJM199711133372001.
   PubMed Web of Science ®Google Scholar
• Demoly P, Louis R, Søes-Petersen U, Naya I, Carlsheimer A, Worth H, Almeida J, Sears MR. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice. Respir Med. 2009;103:1623–32. doi:10.1016/j.rmed.2009.07.018.
   PubMed Web of Science ®Google Scholar
• de la Hoz Caballer B, Rodríguez M, Fraj J, Cerecedo I, Antolín-Amérigo D, Colás C. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study. Am J Rhinol Allergy. 2012;26:390–4. doi:10.2500/ajra.2012.26.3799.
   PubMed Web of Science ®Google Scholar
• Gupta S, Kwan P, Faught E, Tsong W, Forsythe A, Ryvlin P. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: an analysis from the National Health and Wellness Survey. Epilepsy Behav. 2016;55:146–56. doi:10.1016/j.yebeh.2015.12.018.
   PubMed Web of Science ®Google Scholar
• Hone D, Cheng A, Watson C, Huang B, Bitman B, Huang XY, Gandra SR. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States. Arthritis Care Res (Hoboken). 2013;65:1564–72.
   PubMed Web of Science ®Google Scholar
• Stockl KM, Shin JS, Lew HC, Zakharyan A, Harada AS, Solow BK, Curtis BS. Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence. J Manag Care Pharm. 2010;16:593–604.
   PubMed Web of Science ®Google Scholar
• Keystone EC, Taylor PC, Tanaka Y, Gaich C, DeLozier AM, Dudek A, Zamora JV, Cobos JAC, Rooney T, Bono S, et al. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. Ann Rheum Dis. 2017 Aug 10. [Epub ahead of print]. doi:10.1136/annrheumdis-2017-211259.
   PubMed Web of Science ®Google Scholar
• Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005–2009. Natl Health Stat Report. 2011;12:1–14.
   Google Scholar
• Braunstahl GJ, Chen CW, Maykut R, Georgiou P, Peachey G, Bruce J. The eXpeRience registry: the 'real-world' effectiveness of omalizumab in allergic asthma. Respir Med. 2013 Aug;107(8):1141–51. Epub 2013 May 28. doi:10.1016/j.rmed.2013.04.017.
   PubMed Web of Science ®Google Scholar
• Williams SA, Wagner S, Kannan H, Bolge SC. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med. 2009;51:780–5. doi:10.1097/JOM.0b013e3181abb019.
   PubMed Web of Science ®Google Scholar
• Vietri J, Burslem K, Su J. Poor asthma control among US workers: health-related quality of life, work impairment, and health care use. J Occup Environ Med. 2014;56:425–30. doi:10.1097/JOM.0000000000000123.
   PubMed Web of Science ®Google Scholar
• Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, Aikens JE, Hunter CM, Velligan DI, Huntley K, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5:470–82. doi:10.1007/s13142-015-0315-2.
   PubMed Web of Science ®Google Scholar